16 results
424B5
MLYS
Mineralys Therapeutics, Inc.
11 Apr 24
Prospectus supplement for primary offering
4:35pm
subject to special rules, including, without limitation:
U.S. expatriates and certain former citizens or long-term residents of the United States
DEF 14A
MLYS
Mineralys Therapeutics, Inc.
9 Apr 24
Definitive proxy
7:15am
Planning & Analysis at Allergan plc, where she oversaw the company’s long-term financial and business strategy, until its acquisition by AbbVie Inc … consider to be important for the directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more
S-3
MLYS
Mineralys Therapeutics, Inc.
21 Mar 24
Shelf registration
7:30am
limitation:
U.S. expatriates and certain former citizens or long-term residents of the United States;
persons holding our common stock as part
8-K
EX-99.1
4y3vs25kim 9c
7 Nov 23
Mineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:07pm
8-K
no4y yx9j3
14 Sep 23
Departure of Directors or Certain Officers
4:11pm
8-K
EX-99.1
8g0n8julq20au5uwkpa
7 Aug 23
Mineralys Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:08pm
10-Q
sunx9hm q4
15 May 23
Quarterly report
5:25pm
8-K
EX-99.1
7uc7v59m3t
15 May 23
Mineralys Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:04pm
DRS/A
y4tasgk322jx idiwmf
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
2pmto9vgfx g1rbf
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
rs7nex5qzleo7ayiepop
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next